Findings

What do systematic reviews say?

8 questions · 8 findings · 1 reviews · Pain, Palliative and Supportive Care

No studies found 6 · 75%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 25%Moderate 0 · 0%High 0 · 0%

Specific behaviour ‐ agitation · terminally ill adults with delirium

The review found no eligible studies for this question.

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Specific behaviour ‐ agitation · terminally ill adults with delirium

The review found no eligible studies for this question.

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Specific behaviour ‐ agitation · terminally ill adults with delirium

The review found no eligible studies for this question.

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Specific behaviour ‐ agitation · terminally ill adults with delirium

The review found no eligible studies for this question.

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Specific behaviour ‐ agitation · terminally ill adults with delirium

The review found no eligible studies for this question.

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Specific behaviour ‐ agitation · terminally ill adults with delirium

Summary of findings: risperidone showed no clear difference in agitation between 24 and 48 hoursc compared with placebo (low certainty).

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 111 participants
Low

Specific behaviour ‐ agitation · terminally ill adults with severe delirium

The review found no eligible studies for this question.

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Specific behaviour ‐ agitation · terminally ill adults with delirium

Summary of findings: haloperidol showed no clear difference in agitation between 24 and 48 hoursc compared with placebo (low certainty).

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 123 participants
Low